Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hummel

Showing results (331-340 of 385) with videos related to

Pageof 39
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto TrialSibylle Loibl, Denise Treue, Jan Budczies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupAnnette M Staiger, Marita Ziepert, Heike Horn, et al.
Leukemia|March 11, 2025
Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modulesSelina Glaser, Anja Fischer, Juan Emilio Martínez-Manjón, et al.
Nature Medicine|May 4, 2010
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphomaBjörn Lamprecht, Korden Walter, Stephan Kreher, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphomaStephan Kreher, M Amine Bouhlel, Pierre Cauchy, et al.
NPJ Breast Cancer|April 13, 2026
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancerMarion T Van Mackelenbergh, Nicole Pfarr, Karsten Weber, et al.
Blood|June 5, 2014
Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiencyAnne Rensing-Ehl, Simon Völkl, Carsten Speckmann, et al.
Nature|August 16, 2013
Synthetic lethal metabolic targeting of cellular senescence in cancer therapyJan R Dörr, Yong Yu, Maja Milanovic, et al.
Leukemia & Lymphoma|August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYCUlrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
The Journal of Molecular Diagnostics : JMD|June 29, 2021
Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGSMichiel van den Brand, Jos Rijntjes, Markus Möbs, et al.
Pageof 39

Showing results (331-340 of 385) with videos related to

Sort By:
Pageof 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto TrialSibylle Loibl, Denise Treue, Jan Budczies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupAnnette M Staiger, Marita Ziepert, Heike Horn, et al.
Leukemia|March 11, 2025
Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modulesSelina Glaser, Anja Fischer, Juan Emilio Martínez-Manjón, et al.
Nature Medicine|May 4, 2010
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphomaBjörn Lamprecht, Korden Walter, Stephan Kreher, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphomaStephan Kreher, M Amine Bouhlel, Pierre Cauchy, et al.
NPJ Breast Cancer|April 13, 2026
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancerMarion T Van Mackelenbergh, Nicole Pfarr, Karsten Weber, et al.
Blood|June 5, 2014
Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiencyAnne Rensing-Ehl, Simon Völkl, Carsten Speckmann, et al.
Nature|August 16, 2013
Synthetic lethal metabolic targeting of cellular senescence in cancer therapyJan R Dörr, Yong Yu, Maja Milanovic, et al.
Leukemia & Lymphoma|August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYCUlrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
The Journal of Molecular Diagnostics : JMD|June 29, 2021
Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGSMichiel van den Brand, Jos Rijntjes, Markus Möbs, et al.
Pageof 39